Maggot therapy for periocular skin graft failure in the immunocompromised patient

British Journal of Ophthalmology

Volumn 92, Issue 6, 2008, Pages 860-861

  Gericke, A ^a   Pitz, S ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFADROXIL; OFLOXACIN;

ADULT; AGED; BASAL CELL CARCINOMA; BURN SCAR; CANCER SURGERY; CASE REPORT; DEBRIDEMENT; GRAFT FAILURE; HUMAN; HYPEREMIA; IMMUNOCOMPROMISED PATIENT; LETTER; MAGGOT; MAGGOT THERAPY; MALE; OINTMENT; PERIOCULAR SKIN GRAFT FAILURE; PRIORITY JOURNAL; THERMAL INJURY; TREATMENT DURATION; TREATMENT OUTCOME; WOUND CLOSURE;

AGED; ANIMALS; CARCINOMA, BASAL CELL; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; LARVA; MALE; MIDDLE AGED; ORBIT; SKIN NEOPLASMS; SKIN TRANSPLANTATION;

EID: 45249123870     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.129296     Document Type: Letter

References (6)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-91.
2. Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis. Burns 2005;31:403-13.
3. Shankar J, Nair RG, Sullivan SC. Management of periocular skin tumours by laissez-faire technique: analysis of functional and cosmetic results. Eye 2002;16:50-3.
4. Sherman RA. Maggot therapy for foot and leg wounds. Int J Low Extrem Wounds 2002;1:135-42.
5. Whitaker IS, Twine C, Whitaker MJ, et al. Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J 2007;83:409-13.
6. Horobin AJ, Shakesheff KM, Pritchard DI. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by lucilia sericata larval secretions. J Invest Dermatol 2006;126:1410-18.